TICKERNERD
Menu
BTSGBTSGHealthcare · Health Information Services

BTSG Stock Forecast: BrightSpring Health Services, Inc. Price Predictions for 2026-2027

Last close, 13 Oct 2026
$63
−0.57% on the day

The 18 Wall Street analysts covering BrightSpring Health Services, Inc. hold a median 12-month price target of $80 — +27.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 90 of 100 as at 12 Oct 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$12.6B
Ticker Nerd rank
90 / 100
Median analyst target
$80
Analysts covering
18
Revenue$3.9B+23.0% y/y
Operating income$130.4M
Net income$84.2M
Free cash flow$14.9M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−1.7%
1M
+6.7%
YTD
+67.3%
1Y
+112.5%
From 52W high
−14.1%
From 52W low
+112.7%
$29
$73
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

BTSG stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores BrightSpring Health Services, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Oct 2026
90 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
98
Revisions
94
Growth
81
Accruals
76
Issuance
72
Quality
59
Value
53
Volatility
39
Size
13

Momentum (98): The shares have been drifting up relative to others.

Volatility (39): The share price moves around a lot.

Size (13): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

BTSG stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BTSG, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$30$40$50$60$70$80$90Jan 26Apr 26Jul 26Oct 26BTSGHigh $90Median $80Low $70

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says18 analysts
18 Buy0 Hold0 Sell
Low $70Median $80High $90

The green dot is the last close — the median target sits +27.7% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
13 Aug 2026BTIGReiteratesBuy$90
3 Aug 2026BTIGReiteratesBuy$90
3 Aug 2026BTIGReiteratesBuy—
14 July 2026KeybancMaintainsOverweight—
14 July 2026KeybancMaintainsOverweight$60 → $80
14 July 2026Morgan StanleyMaintainsOverweight$71 → $80
14 July 2026Morgan StanleyMaintainsOverweight—
13 July 2026GuggenheimInitiatesBuy—
13 July 2026GuggenheimInitiatesBuy$81
13 July 2026Wells FargoMaintainsOverweight—
13 July 2026Wells FargoMaintainsOverweight$61 → $78
10 July 2026Raymond JamesInitiatesOutperform$80
10 July 2026Raymond JamesInitiatesOutperform—
8 July 2026UBSMaintainsBuy—
8 July 2026UBSMaintainsBuy$63 → $85
2 July 2026B of A SecuritiesMaintainsBuy—
22 June 2026BTIGMaintainsBuy—
18 June 2026TD CowenMaintainsBuy—
8 June 2026Goldman SachsInitiatesBuy—
2 June 2026Morgan StanleyMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BTSG appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

BTSG vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 13 Oct 2026, BrightSpring Health Services, Inc. returned +112.5% against +18.6% for the S&P 500, dividends included.

BTSG vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200250Jan 26Apr 26Jul 26Oct 26BTSGS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

BTSG analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+8.2%
Analysts raising
1
Analysts cutting
0
Fundamentals

BrightSpring Health Services, Inc. (BTSG) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
55.6×

Cheaper than 13% of US stocks

Price / sales
0.9×

Cheaper than 71% of US stocks

Price / book
6.3×

Cheaper than 15% of US stocks

EV / EBITDA
23.9×

Cheaper than 12% of US stocks

Growth & margins
Revenue growth (YoY)
23.0%

Higher than 72% of US stocks

Earnings growth (YoY)
198.8%

Higher than 90% of US stocks

Gross margin
12.7%

Higher than 12% of US stocks

Operating margin
3.4%

Higher than 51% of US stocks

Net margin
2.5%

Higher than 54% of US stocks

Returns & dividend
Return on equity
13.0%

Higher than 71% of US stocks

Return on assets
4.9%

Higher than 76% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

BrightSpring Health Services, Inc. (BTSG) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • BrightSpring Health Services, Inc. has a market value of $12.6B and an enterprise value of $15.0B.

  • Revenue in the twelve months to 30 June 2026: $14.4B. The latest quarter grew 23.0% year on year.

  • Net income over the same four quarters: $365.4M, a 2.5% net margin.

  • Diluted earnings per share, trailing twelve months: $1.67.

  • Free cash flow in the twelve months to 30 June 2026: $402.4M.

  • BrightSpring Health Services, Inc. spent $163.2M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 197.5M.

  • Trailing P/E: 55.6×; forward P/E: 27.6× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • BrightSpring Health Services, Inc. employs 23,500 people — $612K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 13 Oct 2026

Data provided by Twelve Data

Peers

BTSG vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
BTSGBrightSpring Health Services, Inc.$12.6B
90
TEMTempus AI, Inc.$12.2B
24
HNGEHinge Health, Inc.$8.1B
80
HQYHealthEquity, Inc.$7.9B
94
DOCSDoximity, Inc.$5.6B
60
WAYWaystar Holding Corp.$5.1B
36
HTFLHeartFlow, Inc.$4.3B
48

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own BrightSpring Health Services, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest BTSG news & analysis

Top Healthcare Stocks: Playing Offense And Defense For The Win

Seeking Alpha · 12 Oct 2026neutral

A Seeking Alpha article says healthcare may offer both growth potential from forward earnings and defensive support from rising demand amid macroeconomic uncertainty. It cites aging demographics and increased medical spending as drivers of long-term sector growth, while noting that select services and facilities companies show strong forward growth.

Why it matters — BTSG watchers may find the sector outlook relevant because the article highlights healthcare services companies, but it does not discuss BrightSpring specifically.

BTSG Deploys AI Across Operations: Will It Improve Margins?

Zacks Investment Research · 30 Sept 2026positive

BrightSpring Health Services is expanding its use of AI and automation across operations, citing early margin gains and expecting further benefits in later 2026 and 2027.

Why it matters — BTSG watchers would care because the company's AI-led initiatives could drive margin improvements over the coming years.

BrightSpring Health Services, Inc. (BTSG) is a Top-Ranked Value Stock: Should You Buy?

Zacks Investment Research · 30 Sept 2026positive

Zacks Investment Research highlighted BrightSpring Health Services, Inc. (BTSG) as a top-ranked value stock, noting that its Style Scores system can help investors identify strong stocks regardless of their investment approach.

Why it matters — A top-ranked designation from Zacks Style Scores could draw additional investor attention to the stock.

BrightSpring vs. Option Care Health: Which Healthcare Stock Is Better?

Zacks Investment Research · 29 Sept 2026positive

Zacks Investment Research compares BrightSpring Health Services with Option Care Health, noting BrightSpring's faster growth, expansion in pharmacy and provider services, and improving margins against OPCH's slower growth and chronic-therapy pressures.

Why it matters — The comparison highlights BrightSpring's growth and margin improvements as favorable relative to a competitor, which could be relevant for BTSG watchers assessing its market position.

FAQ

Frequently asked questions about BTSG stock

What is the BTSG stock price forecast for 2026-2027?

The 18 Wall Street analysts covering BrightSpring Health Services, Inc. have a median 12-month price target of $80, with estimates ranging from $70 to $90. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is BTSG stock a buy right now?

Of the 18 analysts covering BrightSpring Health Services, Inc., 18 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks BrightSpring Health Services, Inc. 90 out of 100 across roughly 4,600 US stocks as at 12 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank BTSG?

As at 12 Oct 2026, BrightSpring Health Services, Inc. ranks 90 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (98 of 100).

Will BTSG stock go up?

No one can know that. What the data says: the median 12-month target from 18 analysts implies +27.7% from the last close, and Ticker Nerd's factor model ranks BrightSpring Health Services, Inc. 90 out of 100 as at 12 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the BTSG stock forecast for 2030?

No analyst covering BrightSpring Health Services, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BTSG are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $70 to $90 over the next 12 months.

How has BTSG stock performed over the past year?

BrightSpring Health Services, Inc. returned +112.5% over the 12 months to 13 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does BrightSpring Health Services, Inc. do?

BrightSpring Health Services, Inc. is a U.S.

What is the latest news on BTSG?

The most recent item we track (Seeking Alpha, 12 Oct 2026): "Top Healthcare Stocks: Playing Offense And Defense For The Win". A Seeking Alpha article says healthcare may offer both growth potential from forward earnings and defensive support from rising demand amid macroeconomic uncertainty. It cites aging demographics and increased medical spending as drivers of long-term sector growth, while noting that select services and facilities companies show strong forward growth.

Company

About BrightSpring Health Services, Inc.

BrightSpring Health Services, Inc. is a U.S. home and community-based healthcare services platform focused on delivering integrated pharmacy and provider solutions for complex patient populations. The company operates through Pharmacy Solutions and Provider Services, offering services such as infusion and specialty pharmacy, home and community pharmacy, home health care, rehabilitation, and other clinical support services. Its care model serves patients across Medicare, Medicaid, and commercial insurance programs, with an emphasis on coordinated, person-centered care in home and community settings. BrightSpring Health Services plays an important role in the healthcare market by connecting pharmacy capabilities with direct care services, supporting patients who require ongoing, specialized, or chronic care management.

CEO Mr. Jon B. Rousseau · 23,500 employees · United States · https://www.brightspringhealth.com